Treatment of diffuse large B cell lymphoma

Diffuse large B-cell lymphoma is a common form of non-Hodgkin lymphoma. Treatment options include chemotherapy, radiotherapy, targeted therapy, immunotherapy, hematopoietic stem cell transplantation and supportive care. Specific treatment options should be formulated according to the patient's condition. The following is some information about the treatment of diffuse large B-cell lymphoma: 1. Chemotherapy: Chemotherapy is one of the main treatments for diffuse large B-cell lymphoma. Commonly used chemotherapy drugs include cyclophosphamide, doxorubicin, vincristine, prednisone, etc. Chemotherapy can control tumor growth by killing cancer cells. 2. Radiation: Radiotherapy can be used to treat locally recurrent or residual tumors, or to relieve symptoms such as pain and compression. 3. Targeted therapy: Targeted drugs can be used to treat certain targets in diffuse large B-cell lymphoma, such as CD20, CD22, etc. These drugs can specifically attack cancer cells and reduce side effects. 4. Immunotherapy: Immunotherapy is a treatment method that uses the body's immune system to attack cancer cells. For example, chimeric antigen receptor T cell immunotherapy (CAR-T cell therapy) By modifying the patient's own T cells so that they can recognize and attack cancer cells.5. Hematopoietic stem cell transplantation: In some cases, such as patients who relapse after chemotherapy or cannot tolerate chemotherapy, hematopoietic stem cell transplantation can be used as a treatment option.Hematopoietic stem cell transplantation can help patients rebuild their immune system.6. Supportive treatment: During treatment, patients may experience side effects such as nausea, vomiting, hair loss, infection, etc. Supportive care includes nutritional support, pain management, anti-infection therapy, etc. to help patients relieve symptoms and improve quality of life. It is important to note that the treatment of DLBCL should be based on the individual circumstances of the patient, including the stage of the tumor, age, health status, etc. The treatment plan is usually determined by the hematologist and adjusted according to the patient's response to treatment. In addition, patients need to closely cooperate with doctors during treatment, regular review, in order to detect and deal with possible problems in time. For the treatment of diffuse large B-cell lymphoma, great progress has been made, and many patients can obtain better treatment results through comprehensive treatment. If you or someone close to you is diagnosed with diffuse large B-cell lymphoma, it is recommended to consult a professional doctor to learn more about treatment and develop a personalized treatment plan based on your doctor's recommendations.